Preferred Label : Bortezomib/Cyclophosphamide/Dexamethasone-Daratumumab/Hyaluronidase Regimen;
NCIt synonyms : Bortezomib-Cyclophosphamide-Dexamethasone Plus Daratumumab and Hyaluronidase; Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab and Hyaluronidase; Bortezomib/Cyclophosphamide/Dexamethasone Plus Darzalex Faspro; CyBorD-Daratumumab and Hyaluronidase-fihj; Bortezomib-Cyclophosphamide-Daratumumab and Hyaluronidase-Dexamethasone; Bortezomib/Cyclophosphamide/Daratumumab and Hyaluronidase /Dexamethasone Regimen; Bortezomib-Cyclophosphamide-Darzalex Faspro-Dexamethasone; Bortezomib-Cyclophosphamide-Daratumumab and Hyaluronidase -Dexamethasone Regimen; Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab and Hyaluronidase Regimen; Velcade-Cyclophosphamide-Dexamethasone Plus Darzalex Faspro Regimen; Bortezomib/Cyclophosphamide/Daratumumab and Hyaluronidase-fihj/Dexamethasone Regimen; VCD-Daratumumab and Hyaluronidase-fihj; Bortezomib/Cyclophosphamide/Daratumumab and Hyaluronidase /Dexamethasone; Daratumumab and Hyaluronidase-fihj -CyBorD; Bortezomib-Cyclophosphamide-Dexamethasone Plus Daratumumab and Hyaluronidase-fihj; Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab and Hyaluronidase-fihj; Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab/Hyaluronidase Regimen;
NCIt related terms : Dara-CyBorD;
NCIt definition : A regimen containing bortezomib, cyclophosphamide, dexamethasone and daratumumab and
hyaluronidase that may be used in the treatment of systemic light chain amyloidosis.
A dose-modified version may be used for the treatment of systemic light chain amyloidosis.;
NCI Metathesaurus CUI : CL1913815;
Codes from synonyms : 18361;
Origin ID : C198006;
UMLS CUI : C5786711;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
